EDSA logo

Edesa Biotech (EDSA) Cash From Financing

Annual CFF

$592.00 K
-$4.24 M-87.74%

September 30, 2024


Summary


Performance

EDSA Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEDSAcash flowmetrics:

Quarterly CFF

-$31.40 K
-$137.40 K-129.62%

September 30, 2024


Summary


Performance

EDSA Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEDSAcash flowmetrics:

TTM CFF

$592.00 K
-$443.90 K-42.85%

September 30, 2024


Summary


Performance

EDSA TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherEDSAcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

EDSA Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-87.7%-114.8%-64.6%
3 y3 years-95.8%-104.2%-86.6%
5 y5 years+100.0%-104.2%-86.6%

EDSA Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-95.8%at low-100.3%at low-95.6%at low
5 y5-year-95.8%-100.0%-100.3%at low-96.5%+1215.6%
alltimeall time-95.8%-100.0%-100.3%at low-96.9%-100.0%

Edesa Biotech Cash From Financing History

DateAnnualQuarterlyTTM
Sep 2024
$592.00 K(-87.7%)
-$31.40 K(-129.6%)
$592.00 K(-42.9%)
Jun 2024
-
$106.00 K(-49.9%)
$1.04 M(-38.0%)
Mar 2024
-
$211.70 K(-30.7%)
$1.67 M(-24.9%)
Dec 2023
-
$305.70 K(-25.9%)
$2.22 M(-54.0%)
Sep 2023
$4.83 M(-58.5%)
$412.50 K(-44.3%)
$4.83 M(+9.3%)
Jun 2023
-
$741.20 K(-3.1%)
$4.42 M(+20.2%)
Mar 2023
-
$764.60 K(-73.7%)
$3.68 M(-72.4%)
Dec 2022
-
$2.91 M(<-9900.0%)
$13.31 M(+14.5%)
Sep 2022
$11.63 M(-18.0%)
-$300.00(<-9900.0%)
$11.63 M(-1.9%)
Jun 2022
-
$0.00(-100.0%)
$11.85 M(-0.1%)
Mar 2022
-
$10.40 M(+746.7%)
$11.87 M(-11.5%)
Dec 2021
-
$1.23 M(+455.9%)
$13.41 M(-5.4%)
Sep 2021
$14.17 M(+99.8%)
$221.00 K(+1289.9%)
$14.17 M(-17.5%)
Jun 2021
-
$15.90 K(-99.9%)
$17.18 M(+0.3%)
Mar 2021
-
$11.94 M(+498.6%)
$17.14 M(+89.5%)
Dec 2020
-
$2.00 M(-38.2%)
$9.04 M(+27.5%)
Sep 2020
$7.09 M(>+9900.0%)
$3.23 M(<-9900.0%)
$7.09 M(+83.5%)
Jun 2020
-
-$27.50 K(-100.7%)
$3.86 M(-0.7%)
Mar 2020
-
$3.85 M(+8448.4%)
$3.89 M(+8548.4%)
Dec 2019
-
$45.00 K(>+9900.0%)
$45.00 K(-99.5%)
Sep 2019
$0.00(-100.0%)
-
-
Sep 2018
$8.77 M(>+9900.0%)
$0.00(-100.0%)
$8.77 M(0.0%)
Jun 2018
-
$8.77 M(>+9900.0%)
$8.77 M(>+9900.0%)
Sep 2017
$0.00(-100.0%)
$0.00(0.0%)
$0.00(-100.0%)
Jun 2017
-
$0.00(-100.0%)
$5.94 M(-18.7%)
Sep 2016
$7.31 M
$5.94 M(>+9900.0%)
$7.31 M(+405.6%)
DateAnnualQuarterlyTTM
Jun 2016
-
$0.00(0.0%)
$1.45 M(0.0%)
Mar 2016
-
$0.00(-100.0%)
$1.45 M(0.0%)
Dec 2015
-
$1.37 M(+1652.0%)
$1.45 M(+1254.3%)
Sep 2015
$106.80 K(-85.6%)
$78.10 K(>+9900.0%)
$106.80 K(-21.0%)
Jun 2015
-
$0.00(0.0%)
$135.20 K(-10.0%)
Mar 2015
-
$0.00(-100.0%)
$150.30 K(-76.5%)
Dec 2014
-
$28.70 K(-73.1%)
$639.40 K(-94.1%)
Sep 2014
$739.30 K(-93.1%)
-
-
Aug 2014
$10.79 M(+10.9%)
$106.50 K(+605.3%)
$10.79 M(-38.1%)
May 2014
-
$15.10 K(-96.9%)
$17.42 M(-8.1%)
Feb 2014
-
$489.10 K(-95.2%)
$18.96 M(+2.2%)
Nov 2013
-
$10.18 M(+51.0%)
$18.55 M(+90.6%)
Aug 2013
$9.73 M(+1009.3%)
$6.74 M(+332.7%)
$9.73 M(+223.2%)
May 2013
-
$1.56 M(+1896.4%)
$3.01 M(+103.2%)
Feb 2013
-
$78.00 K(-94.3%)
$1.48 M(+5.5%)
Nov 2012
-
$1.36 M(+7235.7%)
$1.40 M(+60.1%)
Aug 2012
$877.20 K(-82.7%)
$18.50 K(-33.7%)
$877.10 K(+1.2%)
May 2012
-
$27.90 K(+2690.0%)
$866.90 K(-7.6%)
Feb 2012
-
$1000.00(-99.9%)
$938.50 K(-20.0%)
Nov 2011
-
$829.70 K(+9896.4%)
$1.17 M(-76.9%)
Aug 2011
$5.07 M(+80.0%)
$8300.00(-91.7%)
$5.07 M(+0.2%)
May 2011
-
$99.50 K(-57.7%)
$5.06 M(+2.0%)
Feb 2011
-
$235.40 K(-95.0%)
$4.96 M(+5.0%)
Nov 2010
-
$4.73 M
$4.73 M
Aug 2010
$2.82 M(+1128.6%)
-
-
Apr 2009
$229.20 K
-
-

FAQ

  • What is Edesa Biotech annual cash flow from financing activities?
  • What is the all time high annual CFF for Edesa Biotech?
  • What is Edesa Biotech annual CFF year-on-year change?
  • What is Edesa Biotech quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for Edesa Biotech?
  • What is Edesa Biotech quarterly CFF year-on-year change?
  • What is Edesa Biotech TTM cash flow from financing activities?
  • What is the all time high TTM CFF for Edesa Biotech?
  • What is Edesa Biotech TTM CFF year-on-year change?

What is Edesa Biotech annual cash flow from financing activities?

The current annual CFF of EDSA is $592.00 K

What is the all time high annual CFF for Edesa Biotech?

Edesa Biotech all-time high annual cash flow from financing activities is $14.17 M

What is Edesa Biotech annual CFF year-on-year change?

Over the past year, EDSA annual cash flow from financing activities has changed by -$4.24 M (-87.74%)

What is Edesa Biotech quarterly cash flow from financing activities?

The current quarterly CFF of EDSA is -$31.40 K

What is the all time high quarterly CFF for Edesa Biotech?

Edesa Biotech all-time high quarterly cash flow from financing activities is $11.94 M

What is Edesa Biotech quarterly CFF year-on-year change?

Over the past year, EDSA quarterly cash flow from financing activities has changed by -$243.10 K (-114.83%)

What is Edesa Biotech TTM cash flow from financing activities?

The current TTM CFF of EDSA is $592.00 K

What is the all time high TTM CFF for Edesa Biotech?

Edesa Biotech all-time high TTM cash flow from financing activities is $18.96 M

What is Edesa Biotech TTM CFF year-on-year change?

Over the past year, EDSA TTM cash flow from financing activities has changed by -$1.08 M (-64.57%)